ZOONO GROUP LIMITED — Earnings Release 2020

Aug 19, 2020

==> picture [130 x 28] intentionally omitted <==

Zoono Group Limited (ASX: ZNO) ASX ANNOUNCEMENT

20 August 2020

Zoono Announces Full Year Results and Maiden Dividend

FY2020 Group Financial Highlights

• Total revenue was NZ$38.3m, up NZ$36.5 from FY19

• Operating EBITDA was NZ$20.6m, up NZ$23m from FY19

• NPAT was $16.7m

• Net assets were $21.0m (including Stock on hand $13.2m)

• Maiden dividend – NZ$0.032 per share

Zoono Group Limited (Company) (ASX: ZNO) is pleased to report strong trading and financial results for full year 2020 with Group EBITDA up 944.5% on the prior corresponding period (FY19).

These results were primarily driven by the increased demand for the Company’s unique products, the efficacy of which is supported by over 100 independent laboratory test results.

When applied to surfaces, Zoono leaves behind a mono-molecular layer that bonds to the surface, protecting it from pathogens for extended periods. Its hand sanitiser also delivers long lasting protection.

Commenting on the results, Managing Director, Mr. Paul Hyslop, said the full year results clearly demonstrate increasing acceptance of the benefit of the Company’s long-lasting antimicrobial products, particularly during the current pandemic.

“The second half of the year was outstanding. The team has done an amazing job keeping up with the unprecedented worldwide demand for our products” Mr Hyslop said.

“Strong sales came from Australia and New Zealand in both the B2B and B2C markets. UK and Europe continue to deliver and, in Asia and China, we are making good progress. We have also recently bought back the US distributor and will be seeking to mirror the success of the UK operations in this region."

"Progress in the Middle East, Africa, Turkey, India, Pakistan and Bangladesh has similarly been made with several new distribution agreements. Zoono is becoming a true global company in the provision of antimicrobial protection."

Importantly, sales into the veterinary and animal health sector continue to grow. We expect this to continue and for this sector to materially contribute to the Company’s revenues going forward.

ZOONO GROUP LIMITED Address : Level 12, 225 George Street, Sydney NSW 2000 ABN: 73 006 645 754 · Web: www.zoono.com

Maiden Dividend

The Board of Zoono is pleased to announce its maiden dividend of NZ$0.032 per share (unfranked) with a record date for entitlement of 7 September 2020. The dividend will be paid on 21 September 2020.

All dividend payments will be made by electronic funds transmission. The Company encourages all shareholders to make sure the Company’s share registry, Boardroom Pty Limited, has their bank account and Tax File Number details.

Results Briefing

Zoono will holding a 2020 full year results briefing via webcast today at 1.00pm (Sydney time).

Analysts and media may also participate via telephone.

This announcement has been authorised and approved for release to ASX by the Board of Zoono Group Limited.

For further information, please contact:

Zoono Group Limited

Paul Hyslop Paul Ravlich Group Managing Director/CEO Group CFO M: +64 21 659977 M: +64 21 0759176 E: paul.hyslop@zoono.com. E: paul.ravlich@zoono.com.

About Zoono

Zoono Group Limited is a global biotech company that develops, manufactures and distributes a suite of scientifically-validated, long-lasting and environmentally-friendly antimicrobial solutions. Zoono’s mission is to improve health and well-being through innovative, safe, nontoxic and durable germ protection.

Zoono produces sprays, wipes and foams suited for skin care, surface sanitisers, and mould remediation treatments. The products are based on the ‘zoono molecule’, a unique antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mould.

Zoono’s products have received numerous regulatory approvals and the company’s technology claims are supported by independent testing conducted in laboratories worldwide. Zoono is headquartered in New Zealand and its products are available globally.

To learn more, please visit: www.zoono.com

Zoono Group Limited (ASX:ZNO) · Level 12, 225 George Street, Sydney NSW 2000 · ABN: 73 006 645 754 · www.zoono.com